Novo Nosedives, New AI Darlings & Buy the Former High-Flyers? 11/24/25

<p>Novo Nordisk hits a 4-year low, just days after rival Eli Lilly hits a $1T market cap milestone.<br />Plus, some former high-flyers trading more down to earth. Is now the time to get in?  And, two unlikely names dominating the AI narrative now.</p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>